{"count": 1, "results": [{"_id": "18217647", "pmid": 18217647, "title": "[A first drug combination for the treatment of arterial hypertension with a calcium channel antagonist (amlodipine besylate) and an angiotensin receptor blocker (valsartan): Exforge].", "journal": "Rev Med Liege", "authors": ["Krzesinski JM", "Scheen AJ"], "date": "2007-11-01T00:00:00Z", "meta_date_publication": "2007 Nov", "meta_volume": "62", "meta_issue": "11", "meta_pages": "688-94", "score": 50074.03, "text_hl": "[A first drug combination for the treatment of @<m>DISEASE_Pulmonary_Arterial_Hypertension</m> @DISEASE_MESH:D000081029 @@@arterial hypertension@@@ with a calcium channel antagonist (@CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine besylate@@@) and an angiotensin receptor blocker (@CHEMICAL_Valsartan @CHEMICAL_MESH:D000068756 @@@valsartan@@@): @<m>CHEMICAL_Amlodipine_Valsartan_Drug_Combination</m> @CHEMICAL_MESH:D000068838 @@@Exforge@@@].", "citations": {"NLM": "Krzesinski JM, Scheen AJ. [A first drug combination for the treatment of arterial hypertension with a calcium channel antagonist (amlodipine besylate) and an angiotensin receptor blocker (valsartan): Exforge]. Rev Med Liege. 2007 Nov;62(11):688-94. PMID: 18217647", "BibTeX": "@article{18217647, title={[A first drug combination for the treatment of arterial hypertension with a calcium channel antagonist (amlodipine besylate) and an angiotensin receptor blocker (valsartan): Exforge].}, author={Krzesinski JM and Scheen AJ}, journal={Rev Med Liege}, volume={62}, number={11}, pages={688-94}}"}}]}